Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca(2+) influx

Aspirin is a well-known nonsteroidal anti-inflammatory drug (NSAID) that may potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance. Aspirin intolerance is accompanied by increased leukotriene (LT) synthesis, and high levels of seru...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 131(2009), 1 vom: 03. Apr., Seite 145-56
1. Verfasser: Togo, Kana (VerfasserIn)
Weitere Verfasser: Suzuki, Yoshihiro, Yoshimaru, Tetsuro, Inoue, Toshio, Terui, Tadashi, Ochiai, Toyoko, Ra, Chisei
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Anti-Inflammatory Agents, Non-Steroidal Calcium Channels, L-Type Salicylates Leukotriene C4 2CU6TT9V48 Immunoglobulin E 37341-29-0 Mitogen-Activated Protein Kinase 3 mehr... EC 2.7.11.24 p38 Mitogen-Activated Protein Kinases Phospholipases A2 EC 3.1.1.4 Aspirin R16CO5Y76E Calcium SY7Q814VUP
LEADER 01000naa a22002652 4500
001 NLM185752985
003 DE-627
005 20231223173039.0
007 cr uuu---uuuuu
008 231223s2009 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2008.09.008  |2 doi 
028 5 2 |a pubmed24n0619.xml 
035 |a (DE-627)NLM185752985 
035 |a (NLM)19144570 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Togo, Kana  |e verfasserin  |4 aut 
245 1 0 |a Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca(2+) influx 
264 1 |c 2009 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.05.2009 
500 |a Date Revised 01.12.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Aspirin is a well-known nonsteroidal anti-inflammatory drug (NSAID) that may potentiate some acute allergies and causes adverse immunological reactions collectively referred to as aspirin intolerance. Aspirin intolerance is accompanied by increased leukotriene (LT) synthesis, and high levels of serum IgE are a risk factor for NSAID sensitivity. Here we demonstrate that aspirin modulates LTC(4) secretion in mast cells. Therapeutic levels of aspirin and salicylates (<or=0.3 mM, i.e., the concentrations observed in vivo in the use of antipyretic analgesic) increased IgE-mediated LTC(4) secretion. Aspirin-induced stimulation was accompanied by increased Ser-505 phosphorylation of cytosolic phospholipase A(2), which occurred independently of extracellular signal-regulated protein kinase-1/2 and p38 mitogen-activated protein kinase pathways. Aspirin also increased IgE-mediated Ca(2+) influx, whereas aspirin at concentrations of >or=0.3 mM dose-dependently reduced Ca(2+) store emptying and Ca(2+) release-activated Ca(2+) channel activation. Instead, aspirin facilitated a dihydropyridine receptor-mediated Ca(2+) influx, resulting in increased LTC(4) secretion. This novel action of aspirin may play roles in exacerbation of immediate allergy and aspirin intolerance 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Anti-Inflammatory Agents, Non-Steroidal  |2 NLM 
650 7 |a Calcium Channels, L-Type  |2 NLM 
650 7 |a Salicylates  |2 NLM 
650 7 |a Leukotriene C4  |2 NLM 
650 7 |a 2CU6TT9V48  |2 NLM 
650 7 |a Immunoglobulin E  |2 NLM 
650 7 |a 37341-29-0  |2 NLM 
650 7 |a Mitogen-Activated Protein Kinase 3  |2 NLM 
650 7 |a EC 2.7.11.24  |2 NLM 
650 7 |a p38 Mitogen-Activated Protein Kinases  |2 NLM 
650 7 |a EC 2.7.11.24  |2 NLM 
650 7 |a Phospholipases A2  |2 NLM 
650 7 |a EC 3.1.1.4  |2 NLM 
650 7 |a Aspirin  |2 NLM 
650 7 |a R16CO5Y76E  |2 NLM 
650 7 |a Calcium  |2 NLM 
650 7 |a SY7Q814VUP  |2 NLM 
700 1 |a Suzuki, Yoshihiro  |e verfasserin  |4 aut 
700 1 |a Yoshimaru, Tetsuro  |e verfasserin  |4 aut 
700 1 |a Inoue, Toshio  |e verfasserin  |4 aut 
700 1 |a Terui, Tadashi  |e verfasserin  |4 aut 
700 1 |a Ochiai, Toyoko  |e verfasserin  |4 aut 
700 1 |a Ra, Chisei  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 131(2009), 1 vom: 03. Apr., Seite 145-56  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:131  |g year:2009  |g number:1  |g day:03  |g month:04  |g pages:145-56 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2008.09.008  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 131  |j 2009  |e 1  |b 03  |c 04  |h 145-56